Medicure Inc.
MPH.V
TSX
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 26.14% | -9.26% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 26.14% | -9.26% | |||
| Cost of Revenue | 27.02% | 4.97% | |||
| Gross Profit | 25.33% | -19.42% | |||
| SG&A Expenses | 20.74% | -11.12% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 24.76% | -6.56% | |||
| Operating Income | -12.94% | -25.22% | |||
| Income Before Tax | -15.12% | -47.79% | |||
| Income Tax Expenses | 58.11% | -69.08% | |||
| Earnings from Continuing Operations | -17.47% | -22.43% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -17.47% | -22.43% | |||
| EBIT | -12.94% | -25.22% | |||
| EBITDA | -59.92% | 64.24% | |||
| EPS Basic | -17.49% | -22.16% | |||
| Normalized Basic EPS | -17.54% | -44.86% | |||
| EPS Diluted | -18.44% | -28.76% | |||
| Normalized Diluted EPS | -17.54% | -44.86% | |||
| Average Basic Shares Outstanding | 0.00% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||